InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Berman Dennis N. Director active across 1 company, notably Inhibikase Therapeutics, Inc.. In total, 1 reports have been published. History available since 30 July 2026. The latest transaction was filed on 30 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration